Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients

Updated: Sep 28, 2018

Irene Ghobrial, MD of Dana-Farber Cancer Institute, Boston, MA, discusses the benefits of early therapeutic interventions for patients with high-risk smouldering multiple myeloma (MM). +watch video

Dana-Farber Cancer Institute logo
Center for Prevention of Progression of Blood Cancers

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy